Skip to main content

Patient with Hypertension and Right Ventricular Enlargement

  • Chapter
  • First Online:
Hypertension and Cardiac Organ Damage

Part of the book series: Practical Case Studies in Hypertension Management ((PCSHM))

  • 607 Accesses

Abstract

Please check if the section headings are assigned to appropriate levels.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.

    Article  PubMed  Google Scholar 

  2. Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013;144(4):1346–56.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Tedford RJ, Mudd JO, Girgis RE, Mathai SC, Zaiman AL, Housten-Harris T, et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail. 2013;6(5):953–63.

    Article  CAS  PubMed  Google Scholar 

  4. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation. 2004;109(2):159–65.

    Article  PubMed  Google Scholar 

  5. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002;346(12):896–903.

    Article  CAS  PubMed  Google Scholar 

  6. Nikpour M, Stevens W, Proudman SM, Buchbinder R, Prior D, Zochling J, et al. Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated? Intern Med J. 2013;43(5):599–603.

    Article  CAS  PubMed  Google Scholar 

  7. Johnson SR, Mehta S, Granton JT. Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review. Eur Respir J. 2006;28(5):999–1004.

    Article  CAS  PubMed  Google Scholar 

  8. Preston IR, Roberts KE, Miller DP, Sen GP, Selej M, Benton WW, et al. Effect of Warfarin treatment on survival of patients with pulmonary arterial hypertension (PAH) in the registry to evaluate early and long-term PAH disease management (REVEAL). Circulation. 2015;132(25):2403–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Caldeira D, Loureiro MJ, Costa J, Pinto FJ, Ferreira JJ. Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis. Can J Cardiol. 2014;30(8):879–87.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Izzo, R. (2017). Patient with Hypertension and Right Ventricular Enlargement. In: Hypertension and Cardiac Organ Damage. Practical Case Studies in Hypertension Management. Springer, Cham. https://doi.org/10.1007/978-3-319-56080-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56080-9_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56079-3

  • Online ISBN: 978-3-319-56080-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics